Eating this popular fruit daily may support postmenopausal heart and metabolic health
Eating fresh mango every day may help to boost women's postmenopausal heart and metabolic health, researchers said Tuesday.
They found that eating about 1.5 cups of the sweet fruit a day for two weeks significantly reduced blood pressure and cholesterol among postmenopausal women living with obesity. Both blood pressure and cholesterol are key indicators of heart health.
'Risk factors like high blood pressure and unhealthy cholesterol are key contributors to cardiovascular disease, but a nutrient-rich diet that includes fresh fruit, like mango, has long been shown to help reduce those risks,' Dr. Roberta Holt, an associate researcher at UC Davis, said in a statement. 'This study shows that even short-term changes — like eating fresh mangos daily — can make a measurable impact on chronic disease risk in certain populations.'
Holt was a co-author of the research which was published Tuesday in the Journal of the American Nutrition Association. The study was supported through an unrestricted grant from the National Mango Board, although the board had no influence over the study.
To reach these conclusions, they examined the health of 24 women between the ages of 50 to 70 years old who were overweight or obese. Before the study period, the authors instructed them to refrain from eating mangos. Over two weeks, the researchers collected baseline measurements, measurements when consumption began during a second visit to their lab, and then more measurements at the third visit.
The women ate mangos in the mornings and the evenings. Two hours after consumption, their resting blood pressure dropped and there was a reduction in average arterial pressure. After consuming mangos every day for two weeks, their total cholesterol was slashed by nearly 13 points and their bad cholesterol dropped by the same amount.
A smaller follow-up with just six participants from the initial study examined insulin and sugar levels after eating the same amount of mango with 83 grams of white bread. The researchers found the women's blood sugar levels rose significantly less after eating mango than after eating white bread. Insulin levels also responded more favorably to mango.
Although mangos are high in natural sugar compared to other fruits, they also provide crucial vitamins and other nutrients. Additional research is needed to determine the effects of mango consumption of heart and metabolic health, but the benefits could aid the 1.3 million U.S. women undergoing menopause: a period when the risk of heart disease rises significantly. Women spend up to 40 percent of their lives in this life stage, and nearly half of American women are affected by cardiovascular disease.
'Post-menopausal women face distinct metabolic changes that can impact their risk of developing cardiovascular disease,' said Holt. 'These findings help to identify targeted dietary strategies, like eating fresh mangos daily, to aid this at-risk population and support cardiovascular wellness and potential reductions in chronic disease risk.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Trump White House: Jill Biden should speak up about Joe Biden's mental health
President Donald Trump's top spokesperson called for former first lady Jill Biden to speak up about former President Joe Biden's alleged mental decline, saying she conspired to keep her husband's health from the American people. White House press secretary Karoline Leavitt's comment on May 29 - that Jill Biden should address 'when she saw and what she knew" - came in response to a reporter's question on whether the former first lady should testify to Congress about the former Democratic president's health. 'I think anybody looking again at the videos and photo evidence of Joe Biden with your own eyes and a little bit of common sense can see that this was a clear coverup,' Leavitt responded. 'And Jill Biden was certainly complicit in that coverup.' More: Robert Hur defends characterization of Biden's memory in testimony to Congress: Recap Aides close to President Biden and his wife did not immediately respond to requests for comment about the growing calls from the Trump White House. The 82-year old Democrat announced last week that he'd been diagnosed with an 'aggressive' Stage 4 prostate cancer. Questions around the president's mental capacity reached a fevered pitch when former Special Counsel Robert Hur released a report in early 2024 about Biden mishandling classified documents after his time as vice president concluded in the Obama White House. Hur concluded that a potential criminal jury would find Biden to be a 'sympathetic, well-meaning elderly man with a poor memory." Biden's performance during a June presidential debate with then-Republican nominee Donald Trump also raised questions about the Democrats' well-being, and he ultimately dropped out of the White House race in deference to then-Vice President Kamala Harris. The Trump White House's focus on Biden echoes criticism from House Oversight Committee Chairman James Comer. The Kentucky Republican has asked several high-ranking Biden administration officials and his physician, Dr. Kevin O'Connor, to appear for transcribed interviews to 'uncover the truth' about Biden's "mental decline and potential unauthorized use of an autopen for sweeping pardons and other executive actions. Letters seeking testimony have been sent to staffers including former senior adviser to the first lady Anthony Bernal, former Domestic Policy Council Director Neera Tanden and former deputy chief of staff Annie Tomasini. Comer said during the last Congress that the Biden White House obstructed his committee's investigation into the president's mental capacity and refused to make aides available for depositions or interviews. 'The American people demand transparency and accountability now,' Comer said in a statement. According to a new book, Original Sin, written by CNN's Jake Tapper and Axios's Alex Thompson, one person familiar with workings of the administration said Biden was only one of five people running the country. During her May 29 briefing at the White House, Leavitt claimed there was documentary evidence showing Jill Biden was shielding her husband from public scrutiny. 'She's still lying to the American people. She still thinks the American public are so stupid that they're going to believe her lies," said Leavitt. "And frankly, it's insulting, and she needs to answer for it.' (This story was updated because an earlier version included an inaccuracy) This article originally appeared on USA TODAY: Leavitt blasts Jill Biden over husband's health 'coverup'
Yahoo
23 minutes ago
- Yahoo
Joe Biden 'optimistic' about treatment plan for Stage 4 prostate cancer
Former President Joe Biden said on May 30 that he is 'optimistic' about the treatment plan for his Stage 4 prostate cancer, which involves taking a daily pill for six weeks. "We're underway and all the folks are very optimistic," Biden said. 'The expectation is we're going to be able to beat this. It's not in any (other) organ. My bones are strong, it hasn't penetrated. So I'm feeling good.' More: Biden urges Americans to support veterans on anniversary of son Beau's death Doctors found a 'small nodule' on Biden's prostate during a routine exam; the 82-year-old was diagnosed Friday, May 16, according to a statement released by his office. Speaking to reporters at a Delaware Memorial Day event for the first time since announcing his diagnosis, Biden said that he is being treated by a top doctor in the field. Biden's physician has lived through the same aggressive form of cancer as the former president. 'We're all optimistic about the diagnosis. Matter of fact, one of the leading surgeons in the world is working with me and he was diagnosed with the same exact thing 32 years ago,' Biden said. 'He's alive and well, doing very well.' Biden spoke with reporters as he left the annual Memorial Day event at Veterans Memorial Park in New Castle, Delaware, which coincided with the 10th anniversary of his son Beau Biden's death. It was also the first time Biden spoke to reporters since a book was published raising questions about his physical and mental fitness while he was president. A White House spokeswoman alleged Thursday that former first lady Jill Biden conspired to keep her husband's health from the American people. When asked to respond, Biden, who had just given a 10-minute speech and walked over to the throng of reporters, joked, "You can see that I'm mentally incompetent and I can't walk." This article originally appeared on USA TODAY: Joe Biden 'optimistic' about cancer treatment, doctor, meds
Yahoo
33 minutes ago
- Yahoo
California petitions FDA to undo RFK Jr.'s new limits on abortion pill mifepristone
California and three other states petitioned the U.S. Food and Drug Administration Thursday to ease its new restrictions on the abortion pill mifepristone, citing the drug's proven safety record and arguing the new limits are unnecessary. "The medication is a lifeline for millions of women who need access to time-sensitive, critical healthcare — especially low-income women and those who live in rural and underserved areas," said California Atty. Gen. Rob Bonta, who filed the petition alongside the attorneys general of Massachusetts, New York and New Jersey. The petition cites Senate testimony by Health and Human Services Secretary Robert F. Kennedy Jr. last month, in which Kennedy said he had ordered FDA administrator Martin Makary to conduct a "complete review" of mifepristone and its labeling requirements. The drug, which can be received by mail, has been on the U.S. market for 25 years and taken safely by millions of Americans, according to experts. It is the most common method of terminating a pregnancy in the U.S., with its use surging after the Supreme Court overturned Roe vs. Wade in 2022. The Supreme Court upheld access to the drug for early pregnancies under previous FDA regulations last year, but it has remained a target of anti-abortion conservatives. The Trump administration has given Kennedy broad rein to shake up American medicine under his "Make America Healthy Again" banner, and Kennedy has swiftly rankled medical experts by using dubious science — and even fake citations — to question vaccine regimens and research and other longstanding public health measures. Read more: Hiltzik: MAHA report's misrepresentations will harm public health and hit consumers' pocketbooks At the Senate hearing, Kennedy cited "new data" from a flawed report pushed by anti-abortion groups — and not published in any peer-reviewed journal — to question the safety of mifepristone, calling the report "alarming." "Clearly, it indicates that, at very least, the label should be changed," Kennedy said. Sen. Josh Hawley (R-Mo.) on Monday posted a letter from Makary to X, in which Makary wrote that he was "committed to conducting a review of mifepristone" alongside "the professional career scientists" at the FDA. Makary said he could not provide additional information given ongoing litigation around the drug. The states, in their 54-page petition, wrote that "no new scientific data has emerged since the FDA's last regulatory actions that would alter the conclusion that mifepristone remains exceptionally safe and effective," and that studies "that have frequently been cited to undermine mifepristone's extensive safety record have been widely criticized, retracted, or both." Democrats have derided Kennedy's efforts to reclassify mifepristone as politically motivated and baseless. "This is yet another attack on women's reproductive freedom and scientifically-reviewed health care," Gov. Gavin Newsom said the day after Kennedy's Senate testimony. "California will continue to protect every person's right to make their own medical decisions and help ensure that Mifepristone is available to those who need it." Bonta said Thursday that mifepristone's placement under the FDA's Risk Evaluation and Mitigation Strategy program for drugs with known, serious side effects — or REMS — was "medically unjustified," unduly burdened patient access and placed "undue strain on the nation's entire health system." He said mifepristone "allows people to get reproductive care as early as possible when it is safest, least expensive, and least invasive," is "so safe that it presents lower risks of serious complications than taking Tylenol," and that its long safety record "is backed by science and cannot be erased at the whim of the Trump Administration." Read more: Q&A: The FDA says the abortion pill mifepristone is safe. Here's the evidence The FDA has previously said that fewer than 0.5% of women who take the drug experience 'serious adverse reactions,' and deaths are exceedingly rare. The REMS program requires prescribers to add their names to national and local abortion provider lists, which can be a deterrent for doctors given safety threats, and pharmacies to comply with complex tracking, shipping and reporting requirements, which can be a deterrent to carrying the drug, Bonta said. It also requires patients to sign forms in which they attest to wanting to "end [their] pregnancy," which Bonta said can be a deterrent for women using the drug after a miscarriage — one of its common uses — or for those in states pursuing criminal penalties for women seeking certain abortion care. Under federal law, REMS requirements must address a specific risk posed by a drug and cannot be "unduly burdensome" on patients, and the new application to mifepristone "fails to meet that standard," Bonta said. The states' petition is not a lawsuit, but a regulatory request for the FDA to reverse course, the states said. If the FDA will not do so nationwide, the four petitioning states asked that it "exercise its discretion to not enforce the requirements" in their states, which Bonta's office said already have "robust state laws that ensure safe prescribing, rigorous informed consent, and professional accountability." Get the L.A. Times Politics newsletter. Deeply reported insights into legislation, politics and policy from Sacramento, Washington and beyond, in your inbox twice per week. This story originally appeared in Los Angeles Times.
